XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Interim Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 45,527,197 $ 48,546,210
Restricted cash 95,032 17,872
Accounts receivable, net 422,796
Inventory 883,376 615,133
Prepaid expenses and other current assets 1,190,555 1,071,963
Total current assets 48,118,956 50,251,178
Other assets 11,429 45,714
Equipment, net 70,452 27,077
Intangible assets, net 407,582 412,969
Total assets 48,608,419 50,736,938
Current liabilities    
Accounts payable and accrued liabilities 2,567,861 2,439,289
Deferred income 239,536
Total current liabilities 2,807,397 3,350,752
Deferred income 202,675
Warrant liabilities 4,672,476 5,820,358
Other long-term liabilities 113,996 102,783
Total liabilities 7,796,544 9,273,893
Stockholders’ equity    
Common shares, no par value, unlimited shares authorized, 16,019,787 shares issued and outstanding as of March 31, 2025, and December 31, 2024 99,128,230 99,128,230
Class B preferred shares, no par value, unlimited shares authorized, 316,655 shares issued and outstanding as of March 31, 2025, and December 31, 2024 62 62
Additional paid-in capital 20,079,465 18,724,092
Accumulated other comprehensive loss (104,301) (104,301)
Accumulated deficit (78,291,581) (76,285,038)
Total stockholders’ equity 40,811,875 41,463,045
Total liabilities and stockholders’ equity 48,608,419 50,736,938
Related Party    
Current liabilities    
Current portion of promissory note - related party $ 911,463